The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux disease.
Ogawa M, Arihiro S, Matsuhashi N, Joh T, Higuchi K, Iwakiri K, Kamiya T, Manabe N, Isshi K, Nakada T, Hokari A, Saruta M, Oshio A, Haruma K, Nakada K.
Ogawa M, et al. Among authors: isshi k.
Esophagus. 2021 Apr;18(2):398-406. doi: 10.1007/s10388-020-00792-z. Epub 2020 Nov 2.
Esophagus. 2021.
PMID: 33136239